Search result for 'chronic weight management'

Eli Lilly India launches Mounjaro, a first-of-its-kind medication for obesity and type 2 diabetes, offering hope for millions in India struggling with these conditions.

Biocon launches Liraglutide, a GLP-1 peptide, in the UK for diabetes and obesity management. This marks the first generic approval for gLiraglutide in a major market.

Biocon inks licensing and supply agreement with Tabuk Pharmaceuticals for commercializing its 'GLP-1' products for diabetes and weight management in the Middle East.

Biocon and South Korea's Handok have signed a licensing and supply agreement for Biocon's Liraglutide, used in chronic weight management, to be commercialized in South Korea.

Biocon has signed a distribution and supply agreement with Medix for its weight management drug, Liraglutide, in Mexico. The partnership aims to provide affordable access to the drug for patients...